Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: Roche | Contract Pharma

What are you searching for?

Sign in
Breaking News, Financial News

Financial Report: Roche

Nutley closure impacts earnings

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Roche
 
1H Revenues: $25.5 billion (+4%)

1H Earnings: $4.6 billion (-14%)

Comments: Pharmaceutical sales were $18.2 billion (+4%). Growth in the half was driven by cancer medicines, hepatitis drug Pegasys, rheumatoid arthritis treatment Actemra/RoActemra and the clinical lab business. Earnings decline was mainly due to costs related to closure of Nutley, NJ operations and productivity measures in Applied Science and Diabetes Care.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters